Journal article
Identification of an excellent prognosis subset of human papillomavirus-associated oropharyngeal cancer patients by quantification of intratumoral CD103 immune cell abundance
B Solomon, RJ Young, M Bressel, J Cernelc, P Savas, H Liu, D Urban, A Thai, C Cooper, T Fua, P Neeson, S Loi, SV Porceddu, D Rischin
Annals of Oncology | Published : 2019
Abstract
Background: Accurate prognostic stratification of human papillomavirus-associated oropharyngeal cancers (HPV+OPSCC) is required to identify patients potentially suitable for treatment deintensification. We evaluated the prognostic significance of CD103, a surface marker associated with tissue-resident memory T cells (TRMs), in two independent cohorts of patients with HPV+OPSCC. Patients and methods: The abundance and distribution of CD103+ immune cells were quantified using immunohistochemistry in a cohort of 189 HPV+OPSCC patients treated with curative intent and correlated with outcome. Findings were then validated in an independent cohort comprising 177 HPV+OPSCCs using univariable and mu..
View full abstractGrants
Awarded by NHMRC
Funding Acknowledgements
Donation to the Peter MacCallum Cancer Foundation from Colin North (no grant number is applicable). NHMRC Career Development Fellowship to BS (APP1110820).